Facial recognition used to identify Lafayette Square protester accused of assault
By Justin Jouvenal, Spencer Hsu,
The Washington Post
| 11. 22. 2020
A line of U.S. Park Police officers pushed protesters back from Lafayette Square on June 1, firing pepper balls and rolling canisters spewing irritant gas into the retreating crowds on H Street NW, video shows.
Amid screams and smoke, a man in a tie-dye T-shirt pulled an officer to the ground and punched him in the face, before disappearing into the chaos, according to charging documents.
The man grabbed another officer, before police caught up with him and attempted to make an arrest, authorities said. But the man wrestled free and vanished once again.
The protester might never have been identified, but an officer found an image of the man on Twitter and investigators fed it into a facial recognition system, court documents state. They found a match and made an arrest.
The court documents are believed to be the first public acknowledgment that authorities used the controversial technology in connection with the widely criticized sweep of largely peaceful protesters ahead of a photo op by President Trump. The case is one of a growing number nationwide in which...
Related Articles
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
